Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer

Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer

We describe a patient with node positive prostate cancer treated with radiation, androgen deprivation, and immunotherapy with long-term overall survival and PSA control. ELISPOT immunoassay studies demonstrated PSA specific T-cells prior to starting vaccine therapy suggesting that this positive resp...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. Kamrava, Kwong Y. Tsang, R. A. Madan, A. Kaushal, C. N. Coleman, J. Gulley
Format:	Article
Language:	English
Published:	Wiley 2009-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2009/363914
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

Evaluation of the association between lymph node ratio and long-term survival in patients after surgery for lymph node-positive bladder cancer: a SEER population-based study with external validation
by: Tao Chen, et al.
Published: (2025-01-01)

Hubungan Usia dan Kadar Prostate Specific Antigen (PSA) dengan Derajat Histopatologi Adenokarsinoma Prostat di RSUD Abdoel Wahab Sjahranie Samarinda
by: Novita Eka Tyas Pratiwi, et al.
Published: (2023-10-01)

Complete PSA Remission without Adjuvant Therapy after Secondary Lymph Node Surgery in Selected Patients with Biochemical Relapse after Radical Prostatectomy and Pelvic Lymph Node Dissection
by: Alexander Winter, et al.
Published: (2012-01-01)

An Improved Multiobjective Algorithm: DNSGA2-PSA
by: Dan Qu, et al.
Published: (2018-01-01)

Dual‐Enhanced SERS Satellite Immuno‐Nanocomplex for Multiple PSA‐Mediated PHI Assay Toward Clinical Prostate Cancer Screening
by: Dong Chen, et al.
Published: (2025-02-01)

Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
by: Clarice F. E. M. Osório, et al.
Published: (2025-01-01)

Long-Term Followup after Electrocautery Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
by: F. Kallenberg, et al.
Published: (2011-01-01)

The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
by: Heikki Seikkula, et al.
Published: (2024-11-01)

Lathyrol affects the expression of AR and PSA and inhibits the malignant behavior of RCC cells
by: Song Shengyou, et al.
Published: (2025-02-01)

Improved Modelling and Assessment of the Performance of Firefighting Means in the Frame of a Fire PSA
by: Martina Kloos, et al.
Published: (2015-01-01)

Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”
by: Lei Qian, et al.
Published: (2022-01-01)

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
by: Mats Steinholtz Ahlberg, et al.
Published: (2022-12-01)

Role of immunotherapy in the overall survival of gastrointestinal cancer patients with liver metastases
by: Taoyuan M Beninato, et al.
Published: (2024-12-01)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
by: Anthony Van Baelen, et al.
Published: (2012-01-01)

Morphometric parameters of pelvic lymph nodes in experimental metastatic prostate cancer
by: V. V. Astashov, et al.
Published: (2023-06-01)

PSA is not suitable as a reliable marker for seminal fluid in rectal samples collected post-mortem
by: Corine Müller, et al.
Published: (2025-07-01)

Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only
by: Stefan Latz, et al.
Published: (2015-01-01)

Extended Salvage Pelvic Lymph Node Dissection in Patients with Recurrent Prostate Cancer
by: Daniar K. Osmonov, et al.
Published: (2014-01-01)

Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
by: Chen Ding, et al.
Published: (2025-02-01)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
by: Gérald E. Piérard, et al.
Published: (2012-01-01)

Prostate Cancer Stereotactic Body Radiation Therapy with Image-guided Radiation Therapy (IGRT) Technique with Three-Dimensional Transperineal Ultrasound for IGRT Tracking of the Prostate
by: Igor Migowski, et al.
Published: (2025-01-01)

Development and Validation of an Immunotherapy-Related Prognostic Signature Based on Lymph Node Ratio for Gastric Cancer
by: Jianxin Li, et al.
Published: (2023-01-01)

The Role of Nonmetastatic Lymph Nodes in the Survival of Colorectal Cancer: A Systematic Review
by: Alexander J. Pennings, MSc, et al.
Published: (2023-12-01)

Focal Treatment of Prostate Cancer with Vascular-Targeted Photodynamic Therapy
by: Scott E. Eggener, et al.
Published: (2008-01-01)

Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis
by: Rachna Ram, et al.
Published: (2014-01-01)

The Chances of Subsequent Cancer Detection in Patients with a PSA > 20 ng/ml and an Initial Negative Biopsy
by: Nadeem Shaida, et al.
Published: (2009-01-01)

Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
by: Helmut Bonkhoff
Published: (2012-01-01)

Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
by: Marka Crittenden, et al.
Published: (2021-04-01)

Does Regular Surveillance Improve the Long-Term Survival of Arteriovenous Fistulas?
by: Ashwin Shetty, et al.
Published: (2012-01-01)

Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival
by: Nasir Hussain, et al.
Published: (2013-01-01)

Extraskeletal Myxoid Chondrosarcoma: Long-Term Survival in the Setting of Metastatic Disease
by: Karim Masrouha, et al.
Published: (2020-01-01)

Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
by: Kuang Youlin, et al.
Published: (2012-01-01)

Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
by: Nan Zhang, et al.
Published: (2025-02-01)

Long-term results of treatment of right-sided colon cancer with mesocolic excision and D3-lymph node dissection
by: S. K. Efetov, et al.
Published: (2014-07-01)

Indoor Pedestrian Positioning Tracking Algorithm with Sparse Anchor Nodes
by: Zhou Yong, et al.
Published: (2013-08-01)

Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01)

Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis
by: Qiming Huang, et al.
Published: (2025-01-01)

Long-Term Survival after Adrenalectomy for Asynchronous Metastasis of Bladder Cancer to the Bilateral Adrenal Glands
by: S. Washino, et al.
Published: (2012-01-01)

Long-Term Follow-Up after Prostatectomy for Prostate Cancer and the Need for Active Monitoring
by: Gregory P. Swanson, et al.
Published: (2020-01-01)